Peter Kölblinger

Research output

Research output per year 2013 2019 2020 2023 2024

• 24 Original Article (Journal)
• 7 Letter to the editor
• 5 Review article
• 3 Case report
• 5 More
  • 3 Editorial
  • 1 unpublished Abstract
  • 1 published Abstract (Journal)

Research output per year

Research output per year

Search results

• 2023

  Usage and benefit of the Internet as a source of information on disease and therapy in dermatology

  Grossschaedl, K., Vallant, C., Dernoscheg, M., Richtig, M., Öllinger, A., Balakirski, G., Wilsmann-Theis, D., Nguyen, V., Weinlich, G., Tsiogka, A. (Co-author), Koelblinger, P. (Co-author), Scheffel, J., Richtig, E. & Richtig, G., 9 Oct 2023, In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 4 p.

  Research output: Contribution to journal › Letter to the editor › peer-review
• 2020

  Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab.

  Harrer, A. (First author), Lang, R. (Co-author) & Kölblinger, P. (Last author), 2020, In: BRITISH JOURNAL OF DERMATOLOGY. 183, 2, p. 404

  Research output: Contribution to journal › Letter to the editor › peer-review
• 2019

  Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab.

  Medek, K. (First author), Koelblinger, P. (Co-author), Koller, J. (Co-author), Diem, A. (Co-author), Ude-Schoder, K., Bauer, J. (Co-author) & Laimer, M. (Last author), 2019, In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 17, 4, p. 448-450

  Research output: Contribution to journal › Letter to the editor › peer-review
  14 Citations (Web of Science)

• Wundheilungsstörungen während der antitumorösen Therapie mit Cetuximab bei schwerer generalisierter dystropher Epidermolysis bullosa.

  Medek, K. (First author), Kölblinger, P. (Co-author), Koller, J. (Co-author), Diem, A. (Co-author), Ude-Schoder, K., Bauer, J. (Co-author) & Laimer, M. (Last author), 2019, In: JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 17, 4, p. 448-450

  Research output: Contribution to journal › Letter to the editor › peer-review
• 2018

  Vismodegib for recurrent locally destructive basal cell carcinoma in a renal transplant patient.

  Koelblinger, P. (First author), Dummer, R., Laimer, M. (Co-author), Hecht, S. (Co-author), Bauer, J. (Co-author), Gaggl, A. (Co-author) & Kugler, A., 2018, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 32, 1, p. e7-e8

  Research output: Contribution to journal › Letter to the editor › peer-review
  2 Citations (Web of Science)
• 2017

  Fulminant type 1 diabetes after adjuvant ipilimumab therapy in cutaneous melanoma

  Tsiogka, A. (First author), Jansky, G. L., Bauer, J. (Co-author) & Koelblinger, P. (Last author), 2017, In: MELANOMA RESEARCH . 27, 5, p. 524-525

  Research output: Contribution to journal › Letter to the editor › peer-review
  28 Citations (Web of Science)
• 2016

  Papillary intralymphatic angioendothelioma (PILA), also referred to as Dabska tumour, in an 83-year-old woman.

  Kugler, A., Koelblinger, P. (Co-author), Zelger, B., Ahlgrimm-Siess, V. (Co-author) & Laimer, M. (Last author), 2016, In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY . 30, 10, p. e59-e61

  Research output: Contribution to journal › Letter to the editor › peer-review
  5 Citations (Web of Science)